Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells

P Bois, J Bescond, B Renaudon, J Lenfant, P Bois, J Bescond, B Renaudon, J Lenfant

Abstract

1. The effect of the bradycardic agent S 16257 on the main ionic mechanisms of diastolic depolarization in sinoatrial node cells isolated from rabbit heart, was investigated by the patch-clamp technique in whole-cell and macro-patch recordings. 2. In whole-cell conditions, S 16257 induced a marked exponential use-dependent blockade of the hyperpolarization-activated I(f) current, without shift of the voltage range of its activation curve. The rate of block increased with the drug concentration. The IC50 for the block of I(f) was 2.8 x 10(-6) M. 3. A similar use-dependent decline of I(f) was obtained with 3 microM S 16257, in cell-attached and in inside out macro-patch configurations, suggesting that the bradycardic agent interacts with I(f) channels from the inside of the cell. 4. A high concentration of S 16257 (10 microM) had no detectable effect on T-type calcium current and slightly decreased L-type calcium current (-18.12 +/- 0.66%), without significant use-dependent blockade. 5. S 16257 had no effect on the delayed outward potassium current Ik at 3 microM and slightly decreased it only at high concentrations, -16.3 +/- 1.2% at 10 microM. In contrast, zatebradine, another bradycardic agent, reduced I k by 20.3 +/- 2.5% at 3 microM. 6. In conclusion, S 16257 may lower heart rate without significant negative inotropic action. In comparison with zatebradine, S 16257 had less effect on Ik suggesting less prolongation of repolarization time.

References

    1. J Physiol. 1986 Aug;377:61-88
    1. Pflugers Arch. 1987 Sep;410(1-2):139-42
    1. J Physiol. 1988 Jan;395:233-53
    1. J Gen Physiol. 1988 Aug;92(2):145-59
    1. Am J Physiol. 1990 Jun;258(6 Pt 2):H1947-51
    1. Pflugers Arch. 1991 Feb;417(6):591-6
    1. Br J Pharmacol. 1995 Jul;115(5):787-94
    1. Physiol Rev. 1993 Jan;73(1):197-227
    1. Pflugers Arch. 1993 Apr;423(1-2):21-7
    1. Br J Pharmacol. 1993 Sep;110(1):343-9
    1. Circulation. 1993 Nov;88(5 Pt 1):2389-401
    1. Br J Pharmacol. 1994 May;112(1):37-42
    1. Eur J Pharmacol. 1992 Dec 8;229(1):55-62

Source: PubMed

3
Abonner